Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-12-04 21:14 |
6K: Transaction documents
|
English | 36.5 KB | ||
| 2024-12-04 18:38 |
PROSPECTUS SUPPLEMENT-472,668 American Depositary Shares
|
English | 1.2 MB | ||
| 2024-12-04 18:38 |
PROSPECTUS SUPPLEMENT-472,668 American Depositary Shares
|
English | 35.8 KB | ||
| 2024-12-03 16:38 |
Purple Biotech Announces $2.8 Million Registered Direct Offering of American De…
|
English | 2.3 MB | ||
| 2024-12-03 16:38 |
Purple Biotech Announces $2.8 Million Registered Direct Offering of American De…
|
English | 36.6 KB | ||
| 2024-12-02 15:13 |
6K- Purple Biotech Reports Positive Final Results from Randomized Phase 2 Study…
|
English | 208.9 KB | ||
| 2024-12-02 15:13 |
6K- Purple Biotech Reports Positive Final Results from Randomized Phase 2 Study…
|
English | 36.7 KB | ||
| 2024-11-16 22:39 |
Reports Third Quarter 2024 Financial Results
|
English | 221.1 KB | ||
| 2024-11-16 22:39 |
Reports Third Quarter 2024 Financial Results
|
English | 36.8 KB | ||
| 2024-11-04 15:59 |
Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology T…
|
English | 180.0 KB | ||
| 2024-11-04 15:59 |
Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology T…
|
English | 36.7 KB | ||
| 2024-10-26 23:56 |
6K: Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK C…
|
English | 202.7 KB | ||
| 2024-10-26 23:56 |
6K: Purple Biotech Presents New Data for its Novel Tri-Specific T Cell and NK C…
|
English | 36.8 KB | ||
| 2024-10-10 16:48 |
6K: Purple Biotech to Present Data for its Tri-Specific Antibody Platform—CAPTN…
|
English | 173.5 KB | ||
| 2024-10-10 16:48 |
6K: Purple Biotech to Present Data for its Tri-Specific Antibody Platform—CAPTN…
|
English | 36.7 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
